X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
sepsis (13) 13
septic shock (12) 12
mortality (10) 10
index medicus (9) 9
prospective studies (9) 9
female (8) 8
male (8) 8
medicine, general & internal (7) 7
middle aged (7) 7
double-blind method (5) 5
hospital mortality (5) 5
infection (5) 5
infections (5) 5
patient outcomes (5) 5
sepsis - drug therapy (5) 5
sepsis - mortality (5) 5
survival analysis (5) 5
aged (4) 4
critical care medicine (4) 4
drug therapy (4) 4
epidemiology (4) 4
intensive care (4) 4
intensive care units (4) 4
medical research (4) 4
medicine (4) 4
outcome (4) 4
patients (4) 4
risk factors (4) 4
adult (3) 3
anti-bacterial agents - therapeutic use (3) 3
biomarkers (3) 3
care and treatment (3) 3
cohort studies (3) 3
definitions (3) 3
disseminated intravascular coagulation (3) 3
drug therapy, combination (3) 3
immunology (3) 3
infectious diseases (3) 3
management (3) 3
protein c - adverse effects (3) 3
proteins (3) 3
recombinant proteins - adverse effects (3) 3
research (3) 3
respiratory distress syndrome (3) 3
risk-factors (3) 3
studies (3) 3
study protocol (3) 3
survival (3) 3
treatment outcome (3) 3
adults (2) 2
anti-infective agents - administration & dosage (2) 2
anti-infective agents - adverse effects (2) 2
anti-infective agents - therapeutic use (2) 2
antibiotics (2) 2
antimicrobial therapy (2) 2
bacteremia (2) 2
bacterial infections (2) 2
cell biology (2) 2
children (2) 2
comorbidity (2) 2
critically ill patients (2) 2
cytokines (2) 2
drug dosages (2) 2
evaluation (2) 2
guidelines (2) 2
hemorrhage - chemically induced (2) 2
hospitalization (2) 2
hospitals (2) 2
icu patients (2) 2
inflammation (2) 2
intensive-care (2) 2
intensive-care units (2) 2
intensive-care-unit (2) 2
medical emergencies. critical care. intensive care. first aid (2) 2
medicine, experimental (2) 2
multicenter (2) 2
outcome assessment (2) 2
outcomes (2) 2
procalcitonin (2) 2
prognosis (2) 2
protein c - therapeutic use (2) 2
quality of life (2) 2
recombinant proteins - therapeutic use (2) 2
regression analysis (2) 2
respiratory system (2) 2
risk (2) 2
sepsis - complications (2) 2
sepsis - epidemiology (2) 2
united-states (2) 2
young adult (2) 2
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv]life sciences [q-bio] (1) 1
abridged index medicus (1) 1
abstracts (1) 1
acquired immune deficiency syndrome (1) 1
acquired immune deficiency syndrome--aids (1) 1
activation (1) 1
acute respiratory distress syndrome (1) 1
acute-phase proteins (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Medicine, ISSN 1741-7015, 09/2017, Volume 15, Issue 1, pp. 172 - 10
Journal Article
by Baykara, Nur and Akalin, Halis and Arslantaş, Mustafa Kemal and Hanci, Volkan and Çağlayan, Çiğdem and Kahveci, Ferda and Demirağ, Kubilay and Baydemir, Canan and Ünal, Necmettin and Özdemir, Pinar and Ulusoy, Hülya and Memis, Dilek and Arar, Cavidan and Yilmaz, Elif and Çelik, Melek and Cinel, Ismail and Temur, Sibel and Yasar, Mehmet Akif and Çulha, Hamdiye Tutan and Balci, Canan and San, Sultan and Salbes, Asena and Özkan, Elçin and Palabiyik, Onur and Çelik, Jale and Yosunkaya, Alper and Çiçekçi, Faruk and Özkoçak, Isil and Kati, Ismail and Basar, Hülya and Turan, Sema and Ünver, Süheyla and Büyükkoçak, Ünase and Akin, Aynur and Gürsoy, Sinan and Tok, Demet and Serin, Simay and Kiter, Seda Dursun and Dogan, Hakan and Oruç, Abdülkadir and Balaban, Onur and Tüfek, Dilara and Kurt, Ibrahim and Bilgi, Murat and Tuna, Verda and Özkök, Aysegül and Sen, Ahmet and Tas, Nilay and Ayoglu, Hilal and Ugur, Berna Kaya and Kaya, Sedat and Kahraman, Mustafa and Doganay, Zahide and Soykam, Gökalp and Köse, Isil and Yelken, Birgül and Ekinci, Osman and Kavak, Gönül Ölmez and Göktas, Ugur and Togal, Türkan and Dogan, Nazim and Gündüz, Murat and Turhanoglu, Selim and Ramazanoglu, Atilla and Eroglu, Füsun and Yalçin, Saban and Yagmurdur, Hatice and Tutak, Atilla and Altunkan, Ali Aydin and Kuyrukluyildiz, Ufuk and Hergünsel, Gülsüm Oya and Erkalp, Kerem and Gökmen, Necati and Aksun, Murat and Sayan, Erkan and Özlü, Onur and Demiraran, Yavuz and Sentürk, Evren and Gençay, Isin and Öksüz, Hafize and Yapici, Nihan and Pirat, Aras and Utku, Tughan and Gedik, Ender and Behret, Orhan and Idin, Kadir and Daskaya, Hayrettin and Ethemoglu, Filiz Banu and Alagöz, Ali and Izdes, Seval and Bayar, Mustafa Kemal and Girgin, Nermin Kelebek and Karabiyik, Lale and Koca, Ugur and Çubukçu, Nurcan and ülger, Fatma and Özgünay, Seyda Efsun and Özcan, Perihan Ergin and Erdivanli, Basar and Tomruk, Senay Göksu and ... and Sepsis Study Grp and Sepsis Study Group
Critical Care, ISSN 1364-8535, 04/2018, Volume 22, Issue 1, pp. 93 - 14
Background: The prevalence and mortality of sepsis are largely unknown in Turkey, a country with high antibiotic resistance. A national, multicenter,... 
Sepsis | Intensive care | Point prevalence | Turkey | Carbapenem resistance | HOSPITAL MORTALITY | PATIENT MORTALITY | STATES | RISK-FACTORS | TRENDS | ORGANISMS | DEFINITIONS | SEPTIC SHOCK | INFECTION | OUTCOMES | CRITICAL CARE MEDICINE | Intensive care units | Services | Drug resistance in microorganisms | Patient outcomes | Mortality | Analysis | Statistics
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/1996, Volume 334, Issue 26, pp. 1697 - 1702
Severe sepsis causes substantial morbidity and mortality among critically ill patients. Despite advances in critical care, the incidence of sepsis continues to... 
INTERLEUKIN-1 | MEDICINE, GENERAL & INTERNAL | FACTOR-BINDING-PROTEIN | CANCER-PATIENTS | SEPSIS SYNDROME | CACHECTIN | ENDOTOXIN | MONOCLONAL-ANTIBODY | SERUM | TNF-ALPHA | FACTOR-ALPHA | Drug therapy | Septic shock | Proteins | Sepsis | Cytokines | Drug dosages | Mortality
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/1997, Volume 336, Issue 13, pp. 912 - 918
Sepsis is associated with a mortality rate of 30 to 50 percent and with substantial morbidity. 1 The relative contributions of the inflammatory response and... 
MEDICINE, GENERAL & INTERNAL | RESPIRATORY-DISTRESS SYNDROME | ESCHERICHIA-COLI ENDOTOXIN | ANTI-INFLAMMATORY DRUGS | CLINICAL-TRIALS | SEPTIC SHOCK | RENAL-FUNCTION | INDOMETHACIN | SHEEP | METHYLPREDNISOLONE | CRITICALLY ILL PATIENTS | Evaluation | Septic shock | Drug therapy | Ibuprofen | Sepsis | Respiratory distress syndrome | Patients | Mortality
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 09/2007, Volume 176, Issue 5, pp. 483 - 490
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/1996, Volume 334, Issue 22, pp. 1417 - 1422
When Ashbaugh et al. 1 described the acute respiratory distress syndrome (ARDS) in 1967, they suggested that the clinical and pathological findings in patients... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | END-EXPIRATORY PRESSURE | SYNTHETIC SURFACTANT | Acute respiratory distress syndrome | Evaluation | Care and treatment | Lung surfactant, Synthetic | Studies | Respiratory distress syndrome | Lungs | Surfactants
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2001, Volume 344, Issue 10, pp. 699 - 709
Journal Article
Journal Article